S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
OCGN · Ocugen, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$0.81
-0.00
(-0.57%)
● At close: October 21 at 4:00:00 PM EDT
$0.81
-0.01
(-0.63%)
Overnight:
1:07:40 AM EDT
DAY'S RANGE
$0.81
$0.79
$0.83
52-WEEK RANGE
$0.81
$0.78
$2.73
What's happening
- OCGN is down 0.57% today, trading at $0.81. — Live quote
- It's trading within 3% of its 52-week low ($0.78). (Finnhub fundamentals)
- Volume today (115,389) is well below its 3-month average of 6,994,680. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.07 actual vs. $-0.05 estimated (-28.7%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 8
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (12 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
OCGN
-39.81%
vs S&P 500
-52.59%
1-YEAR RETURN
OCGN
-49.85%
vs S&P 500
-64.41%
6-MONTH RETURN
OCGN
-57.90%
3-MONTH RETURN
OCGN
-37.50%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.07
Est. $-0.05
MISS -28.7%
2026-04-26 (Q1 2026)
$-0.06
Est. $-0.05
MISS -14.3%
2026-01-26 (Q4 2025)
$-0.06
Est. $-0.06
MISS -1.4%
2025-10-26 (Q3 2025)
$-0.07
Est. $-0.06
MISS -22.6%
Valuation Measures & Ratios
Enterprise Value4$257.5M
Forward P/E5—
PEG Ratio6-0.11
Price / Sales (TTM1)57.30
Price / Book7102.24
EV4 / Revenue53.96
EV4 / EBITDA—
Profit Margin-1343.08%
Operating Margin-1137.46%
Return on Equity (ROE8)-1306.71%
Return on Assets (ROA9)-80.57%
Avg Volume (3M)6,994,680
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $543.7M | $580.1M | — | $285.3M | $216.6M |
| P/E | -6.90 | -8.37 | — | -4.89 | -3.90 |
| Price/Sales | 88.47 | 94.49 | — | 55.61 | 45.39 |
| Price/Book | -32.84 | 99.93 | — | 93.49 | 13.61 |
| EV/Revenue | 72.48 | 94.05 | — | 55.80 | 43.26 |
| ROE | 476.23% | -1194.09% | — | -1911.50% | -348.90% |
| ROA | -63.48% | -121.81% | — | -108.85% | -86.14% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short102,053,118
Change from Prior Settlement-3.78%
% of Float—
Days to Cover (Short Ratio)13.66
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 8.4% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-15; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -1343.1%. Finnhub fundamentals ↗
- Trailing 52-week price return is -49.8%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on OCGN
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5M | $1.5M | $1.8M | $1.4M | $1.5M | $1.1M | $1.1M | $1.0M |
| Operating income | -$16.4M | -$17.8M | -$17.6M | -$13.8M | -$14.5M | -$13.3M | -$15.4M | -$12.2M |
| Net income | -$24.9M | -$19.2M | -$20.1M | -$14.7M | -$15.3M | -$13.0M | -$15.3M | -$11.9M |
| EPS (diluted) | $-0.07 | $-0.06 | — | $-0.05 | $-0.05 | — | $-0.04 | $-0.05 |
| EPS (basic) | $-0.07 | $-0.06 | — | $-0.05 | $-0.05 | — | $-0.04 | $-0.05 |
| Operating margin | -$1.1K | -$1.2K | -$1.0K | -$1.0K | -$979 | -$1.2K | -$1.4K | -$1.2K |
| Net margin | -$1.7K | -$1.3K | -$1.1K | -$1.1K | -$1.0K | -$1.1K | -$1.3K | -$1.2K |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $124.2M | $56.9M | $43.5M | $57.6M | $53.6M | $64.5M | $82.4M | $61.9M |
| Total liabilities | $140.8M | $51.1M | $55.7M | $54.1M | $50.5M | $48.5M | $52.8M | $21.3M |
| Stockholders' equity | -$16.6M | $5.8M | -$12.2M | $3.5M | $3.1M | $15.9M | $29.6M | $40.6M |
| Total current assets | $106.7M | $38.6M | $24.3M | $37.6M | $32.9M | $44.0M | $61.7M | $40.7M |
| Total current liabilities | $133.1M | $20.7M | $23.0M | $20.4M | $18.0M | $16.9M | $21.6M | $15.8M |
| Cash & equivalents | $100.1M | $31.9M | $18.6M | — | $27.0M | $37.8M | — | — |
| Other current assets | $849.0K | $756.0K | $439.0K | — | — | — | $879.0K | — |
| Property, plant & equipment | $13.3M | $13.8M | $14.4M | $14.9M | $15.4M | $16.0M | $16.6M | $17.1M |
| Intangible assets | — | — | — | — | — | — | — | — |
| Other non-current assets | $3.8M | $4.2M | $4.5M | $4.7M | $5.0M | $4.2M | $3.9M | $3.8M |
| Accounts payable | $5.1M | $3.2M | $6.2M | $4.6M | $4.2M | $3.2M | $4.2M | $1.5M |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | $20.0K | $5.0M | $1.2M | $0 | $0 | $0 | $1.3M | $1.3M |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | $1.7M | $24.2M | $27.5M | $28.4M | $28.0M | $27.7M | $27.3M | $1.6M |
| Other non-current liabilities | $2.9M | $3.0M | $1.6M | $1.6M | $583.0K | $573.0K | $564.0K | $554.0K |
| Common stock & paid-in capital | $3.4M | $3.4M | $3.1M | $3.1M | $2.9M | $2.9M | $2.9M | $2.9M |
| Retained earnings | -$452.1M | -$427.2M | -$408.1M | -$390.4M | -$370.3M | -$355.6M | -$340.2M | -$326.3M |
| Accumulated other comprehensive income (loss) | $213.0K | $164.0K | $61.0K | $58.0K | $12.0K | $40.0K | $48.0K | $23.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$12.2M | -$21.8M | -$14.0M | -$12.9M | -$10.7M | -$19.4M | -$10.4M | -$11.3M |
| Investing cash flow | -$21.0K | -$6.0K | -$35.0K | -$86.0K | -$88.0K | -$102.0K | -$13.0K | -$507.0K |
| Financing cash flow | $80.4M | $35.0M | $2.0K | $18.5M | $61.0K | -$1.2M | $30.2M | $34.8M |
| Free cash flow | -$12.2M | -$21.8M | -$14.0M | -$13.0M | -$10.8M | -$19.4M | -$10.4M | -$11.8M |
| Capital expenditures | $21.0K | $6.0K | $35.0K | $91.0K | $43.0K | $16.0K | $13.0K | $507.0K |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | — | — | — | — | — | — | — | — |
| Change in accounts payable | — | — | — | — | — | — | — | — |
| Purchases of investments | — | — | — | — | — | — | $0 | $0 |
| Sales/maturities of investments | — | — | — | — | — | — | $0 | $0 |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $4.4M | $4.1M | $6.0M | $2.5M | — |
| Operating income | -$62.9M | -$54.8M | -$65.5M | -$89.1M | -$58.0M |
| Net income | -$67.8M | -$54.1M | -$63.1M | -$86.8M | -$58.4M |
| EPS (diluted) | — | — | $-0.26 | $-0.40 | $-0.30 |
| EPS (basic) | — | — | $-0.26 | $-0.40 | $-0.30 |
| Operating margin | -$1.4K | -$1.4K | -$1.1K | -$3.6K | — |
| Net margin | -$1.5K | -$1.3K | -$1.0K | -$3.5K | — |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|
| Total assets | $43.5M | $82.4M | $64.5M | $74.7M | $89.0M |
| Total liabilities | $55.7M | $52.8M | $24.0M | $24.9M | $29.7M |
| Stockholders' equity | -$12.2M | $29.6M | $40.6M | $49.8M | $59.2M |
| Total current assets | $24.3M | $61.7M | $43.0M | $56.6M | $73.5M |
| Total current liabilities | $23.0M | $21.6M | $17.1M | $19.7M | $24.5M |
| Cash & equivalents | — | — | $39.5M | $53.5M | $70.6M |
| Other current assets | $439.0K | $879.0K | — | — | — |
| Property, plant & equipment | $14.4M | $16.6M | $17.3M | $14.5M | $11.7M |
| Intangible assets | — | — | — | — | — |
| Other non-current assets | $4.5M | $3.9M | $4.3M | $3.7M | $3.8M |
| Accounts payable | $6.2M | $4.2M | $3.2M | $2.9M | $3.9M |
| Accrued liabilities | — | — | — | — | — |
| Short-term debt | $1.2M | $1.3M | $0 | $1.3M | $1.3M |
| Other current liabilities | — | — | — | — | — |
| Long-term debt | $27.5M | $27.3M | $2.8M | $1.5M | $1.5M |
| Other non-current liabilities | $1.6M | $564.0K | $527.0K | $497.0K | $455.0K |
| Common stock & paid-in capital | $3.1M | $2.9M | $2.6M | $2.6M | $2.6M |
| Retained earnings | -$408.1M | -$340.2M | -$286.2M | -$275.2M | -$263.5M |
| Accumulated other comprehensive income (loss) | $61.0K | $48.0K | $20.0K | $27.0K | $22.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$57.0M | -$42.1M | -$62.1M | -$60.1M | -$47.9M |
| Investing cash flow | -$311.0K | -$3.4M | $3.1M | -$17.0M | -$1.8M |
| Financing cash flow | $17.3M | $64.9M | $20.9M | $59.5M | $120.7M |
| Free cash flow | -$57.1M | -$45.5M | -$72.5M | -$64.5M | -$48.9M |
| Capital expenditures | $185.0K | $3.4M | $10.5M | $4.5M | $939.0K |
| Depreciation & amortization | — | — | — | $480.0K | $229.0K |
| Share-based compensation | — | — | — | — | — |
| Change in accounts payable | — | — | — | — | — |
| Purchases of investments | — | $0 | $3.9M | $13.3M | $0 |
| Sales/maturities of investments | — | $0 | $17.5M | $0 | — |
| Share repurchases | — | — | — | — | $0 |
| Debt issued | — | — | — | $500.0K | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding OCGN as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2024-09-16 to 2026-10-09
Recent transactions
- Insiders have net sold 1,030,982 shares over the last 182 days, across 1 purchase and 4 sales.
- Most recent: Musunuri Shankar (Chief Executive Officer) — Open market sale of 468,727 shares on 2026-10-09.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)21,000 sh(1 txns)
Sales (open market)1,051,982 sh(4 txns)
Net Shares-1,030,982
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Musunuri Shankar | Chief Executive Officer | Open market sale | 2026-10-09 | 468,727 |
| Johnson-Greene Treerita Essalima | Chief Financial Officer | Open market purchase | 2026-06-15 | 21,000 |
| Zhang Junge | Director | Option exercise | 2026-04-01 | 15,000 |
| Ramachandran Ramesh | Chief Accounting Officer | Grant / award | 2026-01-02 | 207,300 |
| Upadhyay Arun | See Remarks | Tax withholding | 2025-01-03 | 41,633 |
| Fernandes Prabhavathi | Director | Open market purchase | 2024-11-26 | 10,000 |
| Castillo Kirsten | Director | Open market purchase | 2024-11-22 | 25,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-09 | Musunuri Shankar | Chief Executive Officer | Open market sale | 468,727 | $0.95 |
| 2026-10-09 | Musunuri Shankar | Chief Executive Officer | Open market sale | 57,264 | $0.95 |
| 2026-09-09 | Musunuri Shankar | Chief Executive Officer | Open market sale | 468,727 | $1.12 |
| 2026-09-09 | Musunuri Shankar | Chief Executive Officer | Open market sale | 57,264 | $1.12 |
| 2026-06-15 | Johnson-Greene Treerita Essalima | Chief Financial Officer | Open market purchase | 21,000 | $1.23 |
| 2026-04-01 | Zhang Junge | Director | Option exercise | 15,000 | $0.51 |
| 2026-04-01 | Zhang Junge | Director | Option exercise | 112,205 | $0.46 |
| 2026-04-01 | Zhang Junge | Director | Option exercise | 66,929 | $1.42 |
| 2026-01-02 | Musunuri Shankar | Chief Executive Officer | Grant / award | 3,123,201 | $0.00 |
| 2026-01-02 | Ramachandran Ramesh | Chief Accounting Officer | Grant / award | 207,300 | $0.00 |
| 2025-01-03 | Upadhyay Arun | See Remarks | Tax withholding | 41,633 | $0.89 |
| 2025-01-03 | Musunuri Shankar | Chief Executive Officer | Tax withholding | 177,146 | $0.89 |
| 2024-11-26 | Fernandes Prabhavathi | Director | Open market purchase | 10,000 | $0.91 |
| 2024-11-22 | Castillo Kirsten | Director | Open market purchase | 25,000 | $0.91 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 05:36 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-15 | 8-K | 2026-10-15 | View on SEC.gov → |
| 2026-10-15 | 8-K | 2026-10-13 | View on SEC.gov → |
| 2026-10-13 | 4 | 2026-10-09 | View on SEC.gov → |
| 2026-10-06 | 8-K | 2026-10-05 | View on SEC.gov → |
| 2026-09-23 | 8-K | 2026-09-21 | View on SEC.gov → |
| 2026-09-11 | 4 | 2026-09-09 | View on SEC.gov → |
| 2026-09-08 | 8-K | 2026-09-01 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-07-13 | 8-K | 2026-07-13 | View on SEC.gov → |
| 2026-06-17 | 4 | 2026-06-15 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-11 | View on SEC.gov → |
Recent news
Headlines about OCGN (Ocugen, Inc.). Links open the publisher — we don’t host full articles.
-
Ocugen's Two Clocks: A Lengthened Stargardt Readout and a 2027 Date With liMeliGhT
AD HOC NEWS · 2026-10-21 -
Ocugen's MENA Deal Is a Ceiling, Not a Floor, With 2027 Data Still the Deciding Vote
AD HOC NEWS · 2026-10-21 -
Ocugen's Roots Deal Defines the Terms of a Payday That Hasn't Arrived
AD HOC NEWS · 2026-10-21 -
Ocugen Inc. stock rises Tuesday, outperforms market
MarketWatch · 2026-10-20 -
H.C. Wainwright sets USD 10.00 target for Ocugen stock
AD HOC NEWS · 2026-10-20 -
Ocugen's MENA Licensing Deal Opens a Commercial Lane That Still Runs Through a 2027 Readout
AD HOC NEWS · 2026-10-20 -
Ocugen Lays Out Three BLA Filings Through 2028 While Its Share Price Sits at a 52-Week Floor - ad-hoc-news.de
ad-hoc-news.de · 2026-10-20 -
Ocugen Trades Near 52-Week Low as Phase 3 Readout Slips to 2027 - ad-hoc-news.de
ad-hoc-news.de · 2026-10-20
No headlines in this category right now — try “All”.